Type I Interferons and Natural Killer Cell Regulation in Cancer

Overview of attention for article published in Frontiers in immunology, March 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter: 14 X users

patent: 3 patents

Citations

dimensions_citation: 118 Dimensions

Readers on

mendeley: 164 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

COMBINATION THERAPY FOR TREATING CANCER WITH AN INTRAVENOUS ADMINISTRATION OF A…

Application WO-2020070303-A1

World Intellectual Property Organisation (WIPO)

COMBINATION THERAPY FOR TREATING CANCER WITH AN INTRAVENOUS ADMINISTRATION OF A…

Application WO-2019038388-A1

World Intellectual Property Organisation (WIPO)

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR MODULATING MONOCYTOPOIESIS

Application WO-2019020593-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.